Liu, Yanxin, Changjiang Dong, Xucheng He, Yamin Shu, Pan Wu, and Jian Zou. “Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System”. Journal of Pharmacy & Pharmaceutical Sciences 25 (December 21, 2022): 377–390. Accessed July 17, 2024. https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/33020.